We attended the BIO 2010 conference to learn more about the confluence of the pharmaceutical and medical device industries in the growing field of personalized medicine. Based on the crowds at the conference and the encouraging stance of the FDA, there is a movement to bring us instrument geeks into the pharmaceutical business.
Designing medical devices can be an expensive undertaking. It can cost thousands of dollars for a traditional setup to make microfluidic chips or a centrifuge to isolate the components of a multi-constituent sample. Luckily, the creative minds that are focused on solving complex, technical problems don’t stop working when there’s a tight budget.
Further advances in microfluidics technology development will educe the most profound breakthroughs in medical diagnostic and therapeutic devices — and ultimately improve patient care.
